Search Results 2911-2920 of 18209 for rheumatoid arthritis
Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage on the ends of your bones ...
A key transcription factor unlocks new potential in stem cell-based embryo models (Dec. 4, 2024); Mayo Clinic unveils cutting-edge AI for precision cancer ...
Hematopoietic growth factor, at least 14 days from last dose; or; Study drug, 30 days or 5 half-lives, whichever is longer, from last dose. Patient ...
... factor support within 14 days prior to registration; Platelets >= 50,000 cells/mm^3 for patients who have bone marrow plasmacytosis < 50% or >= 30,000 cells ...
Significant Hand arthritis (rheumatologic or osteoarthritis). Pregnancy. Electromyographic evidence of any condition other than CTS affecting the hand ...
Recently, antibodies against the proinflammatory cytokine tumor necrosis factor-alpha appeared to be very effective in treating patients with Crohn's disease.
... factor within 4 weeks prior to sample being taken); Platelet count ≥100x10\^9/L. * Screening values of: Alanine aminotransferase (ALT) ≤1.5 x upper limit ...
... factor or other intervention to achieve ANC ≥ 1,000/mm^3 is acceptable) * Platelets ≥ 100,000/mm^3 (Note: the use of transfusion or other intervention to ...
Inflammatory arthritis; Current systemic fungal infection. Renal or liver failure. Prior adverse reaction to corticosteroid. Primary TKA requiring hardware ...
The Mukhopadhyay Tumor Angiogenesis and Vascular Biology Lab at Mayo Clinic studies how vascular endothelial growth factor (VEGF) pathways can be targeted ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.